Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Robert

Showing results (581-590 of 598) with videos related to

Pageof 60
Sort By:
Alzheimer'S Research & Therapy|May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trialsRik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceDae Joong Kang, Naga S Betrapally, Siddhartha A Ghosh, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|November 8, 2006
[Osteochondritis dissecans of the femoral condyles: report of 892 cases]G Lefort, B Moyen, P Beaufils, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Dementia and Geriatric Cognitive Disorders|November 8, 2007
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part IPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Dementia and Geriatric Cognitive Disorders|November 21, 2007
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part IIPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Oncoimmunology|March 25, 2021
Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapseYasmin Kamal, Dennis Dwan, Hannah J Hoehn, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Physical Review Letters|December 1, 2020
First Direct Measurement of ^{22}Mg(α,p)^{25}Al and Implications for X-Ray Burst Model-Observation ComparisonsJ S Randhawa, Y Ayyad, W Mittig, et al.
Pageof 60

Showing results (581-590 of 598) with videos related to

Sort By:
Pageof 60
Alzheimer'S Research & Therapy|May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trialsRik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Hepatology (Baltimore, Md.)|June 25, 2016
Gut microbiota drive the development of neuroinflammatory response in cirrhosis in miceDae Joong Kang, Naga S Betrapally, Siddhartha A Ghosh, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|November 8, 2006
[Osteochondritis dissecans of the femoral condyles: report of 892 cases]G Lefort, B Moyen, P Beaufils, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.
Dementia and Geriatric Cognitive Disorders|November 8, 2007
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part IPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
Dementia and Geriatric Cognitive Disorders|November 21, 2007
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part IIPauline Aalten, Frans R J Verhey, Marina Boziki, et al.
The New England Journal of Medicine|January 24, 2014
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's diseaseStephen Salloway, Reisa Sperling, Nick C Fox, et al.
Oncoimmunology|March 25, 2021
Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapseYasmin Kamal, Dennis Dwan, Hannah J Hoehn, et al.
Neurology|July 26, 2015
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trialsEnchi Liu, Mark E Schmidt, Richard Margolin, et al.
Physical Review Letters|December 1, 2020
First Direct Measurement of ^{22}Mg(α,p)^{25}Al and Implications for X-Ray Burst Model-Observation ComparisonsJ S Randhawa, Y Ayyad, W Mittig, et al.
Pageof 60